Quarterly results round-up: Baxter beat guidance, Boston "in line" but CRM still a problem
This article was originally published in Clinica
Executive Summary
Baxter International has beaten its revenue and earnings-per-share guidance during its first fiscal quarter: net revenues and income were both up 3% at $3.39bn and $588m, respectively. Earnings per diluted share were $1.04 during Q1, a 6% year-on-year increase.